Neumora Therapeutics, Inc.
NMRACIK 0001885522 · Every Form 4 filed by insiders at this issuer.
Filings
7
Latest Feb 16, 2024
Unique insiders
7
Showing
7 of 7
Page 1
Top insiders
Most active reporters at Neumora Therapeutics, Inc.
| Name | Roles | Filings |
|---|---|---|
| Aurora Daljit Singh | Officer | 1 |
| BERNS PAUL L | Director | 1 |
| Gosebruch Henry O | OfficerDirector | 1 |
| Lenz Robert A. | Officer | 1 |
| Milligan Michael Lee | Officer | 1 |
| Pinto Joshua | Officer | 1 |
| Suh Carol Y. | Officer | 1 |
All filings
7 Form 4 / 4-A filings, newest first
| Filed | Insider | Top transaction | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Feb 16, 2024 | Lenz Robert A. Head of R&D | A | 50,000 | $0.00 | $0 | |
| Feb 16, 2024 | Milligan Michael Lee See Remarks | A | 20,625 | $0.00 | $0 | |
| Feb 16, 2024 | Gosebruch Henry O President & CEO · Director | A | 80,000 | $0.00 | $0 | |
| Feb 16, 2024 | BERNS PAUL L Director | A | 171,250 | $0.00 | $0 | |
| Feb 16, 2024 | Suh Carol Y. Chief Operating Officer | A | 85,000 | $0.00 | $0 | |
| Feb 16, 2024 | Aurora Daljit Singh Chief Strategy Officer | A | 97,500 | $0.00 | $0 | |
| Feb 16, 2024 | Pinto Joshua Chief Financial Officer | A | 85,000 | $0.00 | $0 |
Showing 1–7 of 7
Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.